Engineered For Airway Management

Inspired by aerodynamics, the Spiration Valve redirects air away from diseased or damaged lung to healthier tissue, all while allowing trapped air and secretions to escape, so that patients may breathe easier. 

Unlike a stent, the unique design of the Spiration Valve minimizes contact with the bronchial wall, maintains position to redirect air even in complex patients, and facilitates removal when needed. 

The Spiration Valve System is intended to treat severely diseased lung in patients with heterogeneous emphysema and evidence or markers of low collateral ventilation such as complete fissures, or damaged lung resulting in air leaks by limiting airflow to selected areas.

The procedure is considered minimally invasive and can be performed through a flexible bronchoscope.

On inhalation, the Spiration Valve conforms to the airway and redirects air to healthier tissues of the lung.

 

On exhalation, the Spiration Valve flexibly constricts with the airways, allowing trapped air and secretions to escape naturally along the bronchial wall between the umbrella struts.

 

Redirecting Airflow to Redirect Outcomes

Treatment with bronchial valves in patients with severe emphysema was developed to achieve lobar volume reduction without the risks of mortality and morbidity associated with surgical procedures. Studies suggest that an optimal treatment approach for bronchial valve treatment may involve complete occlusion of a single lobe, and careful selection of appropriate patients with complete fissures and high heterogeneity using HRCT and perfusion scan analysis.1,2,3  Learn more about selecting appropriate patients that may benefit from the Spiration Valve System.

Spiration Valve treatment benefits may include reduction in hyperinflation, improvements in pulmonary function as indicated by an improvement in FEV1, improved exercise tolerance, and improved quality of life as measured by SGRQ.1,2


Inspiration Meets Innovation

The valve consists of a Nitinol frame covered with a polymer membrane and five anchors that securely engage the airway walls at the targeted treatment location.

 

Stays in Place
The first and only valve with anchors for
0% migration and expectoration2, 4, 5
Greater Airway Access
Catheters for 2.0mm and 2.6mm
working channels
Redirects Air
The first and only valve without a pressure
fit, allowing secretions to escape naturally
along the bronchial wall
Removable
The first and only valve with a center
rod to facilitate removal

 

Largest Range of Valve Sizes

Now available in 9mm size for large airways.

 

Spiration Valve System Technology

Deployment Catheter and Loader

Model Name

Article Number

Catheter Working Length

Bronchoscope Channel Inner Diameter

Valve Size Compatibility

IBV-C26N

N5381300

1020mm

2.6mm or greater

For 5, 6, 7 and 9mm Valves

IBV-C20

N3521830

1140mm

2.0mm or greater

For 5, 6 and 7mm Valves

 

Spiration Valves

Model Name

Article Number

Valve Size

Cartridge Color

Number Required Per Procedure

IBV-V5

N3495330

5mm

Blue

Determined by number of target locations

IBV-V6

N3495430

6mm

Yellow

IBV-V7

N3495530

7mm

Green

IBV-V9

N5381200

8mm

Grey

 

Airway Sizing Kit

Model Name

Article Number

Gauge Hole

Glass Syringe

Number Required Per Procedure

IBV-VSK

N5534500

Sized for appropriate
valve selection

500 microliters

1

 

Required Ancillary Equipment Needed for Each Procedure

  • Flexible bronchoscope with a working channel inner diameter of 2.0mm or greater
  • Olympus balloon catheter B5-2C
  • Bronchoscopy forceps appropriate for valve removal
  • Standard 10cc sterile syringe with Luer-lock for use in preparing the balloon catheter
  • Sterile saline

Learn More

  • CLICK HERE to learn more about selecting appropriate patients that may benefit from the Spiration Valve System
  • CLICK HERE to learn more about the minimally invasive procedure
  • CLICK HERE for information on the clinical studies supporting the use of bronchial valves for the treatment of emphsyema

FOOTNOTES

  1. Eberhardt R, Gompelmann D, Schuhmann M, et al. Complete Unilateral vs Partial Bilateral Endoscopic Lung Volume Reduction in Patients With Bilateral Lung Emphysema.  Chest 2012;142(4):900-908; doi:10.1378/chest.11-2886
  2. Springmeyer S, Bolliger C, Waddell K, et al. Treatment of Heterogeneous Emphysema Using the Spiration IBV Valves. Thorac Surg Clin 2009; 19:247-253
  3. Sciurba FC, Ernst AE, Herth FJF, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010:363: 1233-44
  4. Elstad. Am J Respir Crit Care Med 2012; 185:A1112.
  5. Ninane. Eur Respir J 2012; 39:1319–1325.